NAD+ Injection 500 mg

NAD+ Injection 500 mg/Vial is a sterile pharmaceutical preparation containing Nicotinamide Adenine Dinucleotide (NAD+), a naturally occurring coenzyme present in all living cells. In regulated pharmaceutical settings, NAD+ formulations are categorized under metabolic and biochemical support products and are handled strictly as prescription-only injectable preparations. This product is intended exclusively for international pharmaceutical trade and institutional supply, not for direct consumer use.

Active Ingredient

• Nicotinamide Adenine Dinucleotide (NAD+) – 500 mg per vial
  NAD+ is a biologically active coenzyme involved in cellular energy metabolism and redox reactions at the molecular level.

Therapeutic Use
From an informational and regulatory perspective, NAD+ injections are supplied to licensed healthcare institutions and distributors for use within approved medical frameworks, clinical protocols, or research-based therapeutic programs, subject to local regulatory approvals. AmeriDrugs does not provide medical advice, treatment guidance, or patient-level usage recommendations.

Dosage Form

• Sterile injectable solution

• Supplied in single-dose glass vials suitable for parenteral administration

• Administration routes are determined solely by qualified medical professionals in accordance with local regulations

Quality & Manufacturing Standards
NAD+ Injection 500 mg/Vial is manufactured in facilities that follow internationally recognized pharmaceutical quality systems, such as WHO-GMP or equivalent GMP standards. Production includes validated sterile manufacturing processes, controlled environments, and batch-level quality testing to ensure consistency, purity, and compliance with export market requirements.

Packaging Information

• Amber glass vial with secure rubber stopper and aluminium seal

• Export-oriented secondary packaging designed to maintain product integrity during international transportation

• Packaging configurations may vary based on importer and regulatory needs

Target Buyers
This product is supplied strictly to:

• Licensed pharmaceutical importers and distributors

• Hospitals and clinical institutions

• Government and private healthcare procurement agencies

• Authorized research and medical supply organizations

It is not intended for retail pharmacies or direct-to-consumer sale.

Regulatory & Compliance Note
NAD+ Injection 500 mg/Vial is a prescription-only injectable product. Importation, distribution, and use are subject to the pharmaceutical laws and regulatory frameworks of the destination country. Buyers are responsible for ensuring compliance with local drug authority approvals, documentation, and licensing requirements. AmeriDrugs operates as an export-focused pharmaceutical supplier and does not promote or market this product for self-use or non-regulated applications.